Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kayoko Matsunami

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
BMC Microbiology|December 5, 2018
Characterization of hepatitis B virus with complex structural variationsKei Fujiwara, Kentaro Matsuura, Kayoko Matsunami, et al.
Virus Research|June 20, 2017
Novel non-canonical genetic rearrangements termed "complex structural variations" in HBV genomeKei Fujiwara, Kayoko Matsunami, Etsuko Iio, et al.
Viruses|September 20, 2019
Novel Genetic Rearrangements Termed "Structural Variation Polymorphisms" Contribute to the Genetic Diversity of OrthohepadnavirusesKei Fujiwara, Kentaro Matsuura, Kayoko Matsunami, et al.
Japanese Journal of Infectious Diseases|March 2, 2018
Clinical Evaluation of Hepatocarcinogenesis and Outcome Using a Novel Glycobiomarker Wisteria floribunda Agglutinin-Positive Mac-2 Binding Protein (WFA<sup>+</sup>-M2BP) in Chronic Hepatitis C with Advanced FibrosisTakako Inoue, Yuji Tsuzuki, Etsuko Iio, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|August 24, 2017
Changes in serum lipid profiles caused by three regimens of interferon-free direct-acting antivirals for patients infected with hepatitis C virusTakako Inoue, Takaaki Goto, Etsuko Iio, et al.
Journal of Gastroenterology|December 31, 2017
High levels of serum Mac-2-binding protein glycosylation isomer (M2BPGi) predict the development of hepatocellular carcinoma in hepatitis B patients treated with nucleot(s)ide analoguesNoboru Shinkai, Masanori Nojima, Etsuko Iio, et al.
Digestive Endoscopy : Official Journal of the Japan Gastroenterological Endoscopy Society|August 29, 2012
The efficacy of transcatheter arterial embolization as the first-choice treatment after failure of endoscopic hemostasis and endoscopic treatment resistance factorsTakahito Katano, Tsutomu Mizoshita, Kyoji Senoo, et al.
Plos One|February 19, 2015
Validation of cross-genotype neutralization by hepatitis B virus-specific monoclonal antibodies by in vitro and in vivo infectionSusumu Hamada-Tsutsumi, Etsuko Iio, Tsunamasa Watanabe, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 24, 2017
Clinical evaluation of sofosbuvir/ledipasvir in patients with chronic hepatitis C genotype 1 with and without prior daclatasvir/asunaprevir therapyEtsuko Iio, Noritomo Shimada, Koichi Takaguchi, et al.
Journal of Gastroenterology|November 2, 2018
TLL1 variant associated with development of hepatocellular carcinoma after eradication of hepatitis C virus by interferon-free therapyEtsuko Iio, Kentaro Matsuura, Noritomo Shimada, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
BMC Microbiology|December 5, 2018
Characterization of hepatitis B virus with complex structural variationsKei Fujiwara, Kentaro Matsuura, Kayoko Matsunami, et al.
Virus Research|June 20, 2017
Novel non-canonical genetic rearrangements termed "complex structural variations" in HBV genomeKei Fujiwara, Kayoko Matsunami, Etsuko Iio, et al.
Viruses|September 20, 2019
Novel Genetic Rearrangements Termed "Structural Variation Polymorphisms" Contribute to the Genetic Diversity of OrthohepadnavirusesKei Fujiwara, Kentaro Matsuura, Kayoko Matsunami, et al.
Japanese Journal of Infectious Diseases|March 2, 2018
Clinical Evaluation of Hepatocarcinogenesis and Outcome Using a Novel Glycobiomarker Wisteria floribunda Agglutinin-Positive Mac-2 Binding Protein (WFA<sup>+</sup>-M2BP) in Chronic Hepatitis C with Advanced FibrosisTakako Inoue, Yuji Tsuzuki, Etsuko Iio, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|August 24, 2017
Changes in serum lipid profiles caused by three regimens of interferon-free direct-acting antivirals for patients infected with hepatitis C virusTakako Inoue, Takaaki Goto, Etsuko Iio, et al.
Journal of Gastroenterology|December 31, 2017
High levels of serum Mac-2-binding protein glycosylation isomer (M2BPGi) predict the development of hepatocellular carcinoma in hepatitis B patients treated with nucleot(s)ide analoguesNoboru Shinkai, Masanori Nojima, Etsuko Iio, et al.
Digestive Endoscopy : Official Journal of the Japan Gastroenterological Endoscopy Society|August 29, 2012
The efficacy of transcatheter arterial embolization as the first-choice treatment after failure of endoscopic hemostasis and endoscopic treatment resistance factorsTakahito Katano, Tsutomu Mizoshita, Kyoji Senoo, et al.
Plos One|February 19, 2015
Validation of cross-genotype neutralization by hepatitis B virus-specific monoclonal antibodies by in vitro and in vivo infectionSusumu Hamada-Tsutsumi, Etsuko Iio, Tsunamasa Watanabe, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 24, 2017
Clinical evaluation of sofosbuvir/ledipasvir in patients with chronic hepatitis C genotype 1 with and without prior daclatasvir/asunaprevir therapyEtsuko Iio, Noritomo Shimada, Koichi Takaguchi, et al.
Journal of Gastroenterology|November 2, 2018
TLL1 variant associated with development of hepatocellular carcinoma after eradication of hepatitis C virus by interferon-free therapyEtsuko Iio, Kentaro Matsuura, Noritomo Shimada, et al.
Pageof 2